Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older
Clinical trial NCT04904549 · TERMINATED
Trial details
- NCT number
- NCT04904549
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-26
- Primary completion
- 2024-08-31
- Enrollment
- 23670
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.